The ???Uber of Biotech??? Gets Back To Work

Hilary Kramer discusses biotech stocks, outlines their risks and compares the industry leader to Uber.

  • by:
  • 08/21/2022
ad-image

By Hilary Kramer

Forget the ???FANG??? group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.

I love these stocks. When they???re rallying, they???re a play on pure innovation. This is because they generate wealth for shareholders on what boils down to the confidence that medical science will keep advancing.

The upside is practically infinite. After all, most computer tools only improve life in increments, make us a little more productive day by day and expand our existing reach.

Biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.

Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.

We???ve seen a few of these stocks on my Turbo Trader list soar 50 percent year to date. That???s true transformative upside. It???s exhilarating.

Click here to read more.

Image:

Opinion

View All

RAW EGG NATIONALIST to JACK POSOBIEC: Affluent leftist radicals are the real domestic threat—just look at the J6 pipebombing suspect

"These leftist agitators, these anarchist agitators, a lot of them aren't from the lumpenproletariat,...

Trump, leaders of Congo and Rwanda sign Washington Accords peace deal

The signing took place at the US Institute of Peace, where Trump said the deal finalizes terms first ...

MICHELLE MALKIN: How did Obamacare waivers work out for big corporations? (2012)

Answer: In the same miserable boat as every other unlucky business struggling with the crushing costs...

BRENDAN PHILBIN: Public schools are failing students by obstructing free speech rights

By silencing critics, pushing politics, or imposing beliefs, school districts fail in their central m...